Kingwood Medical Center announced they are now the only facility in northeast Houston to offer men 50 years and older the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH). Cleared by the U.S. Food and Drug Administration in 2013, the UroLift System ® is designed to relieve symptoms caused by an enlarged prostate, while preserving sexual function.

“Kingwood Medical Center is committed to providing patients with the highest quality, most effective options to address their urology needs,” said Melinda Stephenson, Kingwood Medical Center’s chief executive officer. “The UroLift System® has an excellent safety profile and provides men suffering from an enlarged prostate a beneficial first-line treatment alternative to drug therapy or more invasive surgery. Additionally, the UroLift System® provides fast and meaningful relief from BPH symptoms, improving overall quality of life for our patients”, said Justin Gyorfi, M.D. Urology.

The UroLift System® permanent implants, delivered during a minimally invasive procedure, act like window curtain tiebacks to hold the lobes of an enlarged prostate open. Patients recover from the procedure quickly, and return to their normal routines with minimal downtime.

Data from clinical trials showed that patients receiving UroLift® implants reported rapid symptomatic improvement, improved urinary flow rates, and sustained sexual function.

Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.

More than 500 million aging men worldwide have an enlarged prostate. Medication is often the first line therapy but relief can be inadequate and temporary. Side effects of treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts or ablates prostate tissue to open the blocked urethra. While current surgical options, such as the 'gold standard' surgery, Transurethral Resection of the Prostate (TURP), can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction.

The UroLift System® provides an alternative to tissue removing surgery for the treatment of an enlarged prostate. Performed through the urethra, a urologist uses the UroLift System® to push aside the obstructive prostate lobes and positions small, tailored permanent UroLift® implants to hold the prostate lobes in the retracted position. This opens the urethra while leaving the prostate intact. Adverse reactions associated with UroLift System® treatment were comparable to other minimally invasive surgical therapies as well as standard cystoscopy. The most common adverse events reported during the study included pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate, and the inability to control urine because of an urgent need to urinate.  Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.

Dr. Gyorfi is a board certified urologist, specializing in general urology including the management of kidney stones, prostate disease, female voiding dysfunction, oncology and robotic surgery. Dr. Gyorfi graduated from University of Texas Medical Branch School of Medicine in 2009. He practices in Kingwood through the Premier Urology Group. For more information, please visit http://urolift.com/ and for physician referral visit KingwoodMedical.com or call 800.258.5064.